nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CYP1A1—chronic obstructive pulmonary disease	0.488	1	CbGaD
Arsenic trioxide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0306	0.215	CbGbCtD
Arsenic trioxide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0207	0.146	CbGbCtD
Arsenic trioxide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0197	0.139	CbGbCtD
Arsenic trioxide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0176	0.124	CbGbCtD
Arsenic trioxide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0172	0.121	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0163	0.114	CbGbCtD
Arsenic trioxide—AKT1—leg—chronic obstructive pulmonary disease	0.0114	0.0996	CbGeAlD
Arsenic trioxide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0726	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00975	0.0686	CbGbCtD
Arsenic trioxide—CCND1—respiratory system—chronic obstructive pulmonary disease	0.00403	0.0352	CbGeAlD
Arsenic trioxide—CCND1—connective tissue—chronic obstructive pulmonary disease	0.00354	0.031	CbGeAlD
Arsenic trioxide—MAPK1—respiratory system—chronic obstructive pulmonary disease	0.00339	0.0297	CbGeAlD
Arsenic trioxide—CCND1—bronchus—chronic obstructive pulmonary disease	0.00331	0.029	CbGeAlD
Arsenic trioxide—CCND1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00324	0.0283	CbGeAlD
Arsenic trioxide—TXNRD1—respiratory system—chronic obstructive pulmonary disease	0.00316	0.0276	CbGeAlD
Arsenic trioxide—MAPK3—respiratory system—chronic obstructive pulmonary disease	0.003	0.0262	CbGeAlD
Arsenic trioxide—MAPK1—connective tissue—chronic obstructive pulmonary disease	0.00299	0.0261	CbGeAlD
Arsenic trioxide—CCND1—trachea—chronic obstructive pulmonary disease	0.00298	0.026	CbGeAlD
Arsenic trioxide—AKT1—respiratory system—chronic obstructive pulmonary disease	0.00283	0.0248	CbGeAlD
Arsenic trioxide—TXNRD1—connective tissue—chronic obstructive pulmonary disease	0.00278	0.0243	CbGeAlD
Arsenic trioxide—MAPK1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00273	0.0239	CbGeAlD
Arsenic trioxide—MAPK3—connective tissue—chronic obstructive pulmonary disease	0.00264	0.0231	CbGeAlD
Arsenic trioxide—TXNRD1—bronchus—chronic obstructive pulmonary disease	0.0026	0.0227	CbGeAlD
Arsenic trioxide—TXNRD1—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.501	CbGdCrCtD
Arsenic trioxide—TXNRD1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00254	0.0222	CbGeAlD
Arsenic trioxide—AKT1—connective tissue—chronic obstructive pulmonary disease	0.00249	0.0218	CbGeAlD
Arsenic trioxide—MAPK3—bronchus—chronic obstructive pulmonary disease	0.00247	0.0216	CbGeAlD
Arsenic trioxide—JUN—respiratory system—chronic obstructive pulmonary disease	0.00247	0.0215	CbGeAlD
Arsenic trioxide—IKBKB—respiratory system—chronic obstructive pulmonary disease	0.00245	0.0214	CbGeAlD
Arsenic trioxide—MAPK3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00242	0.0211	CbGeAlD
Arsenic trioxide—TXNRD1—trachea—chronic obstructive pulmonary disease	0.00233	0.0204	CbGeAlD
Arsenic trioxide—AKT1—bronchus—chronic obstructive pulmonary disease	0.00233	0.0204	CbGeAlD
Arsenic trioxide—AKT1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00228	0.0199	CbGeAlD
Arsenic trioxide—MAPK3—trachea—chronic obstructive pulmonary disease	0.00222	0.0194	CbGeAlD
Arsenic trioxide—JUN—connective tissue—chronic obstructive pulmonary disease	0.00217	0.019	CbGeAlD
Arsenic trioxide—IKBKB—connective tissue—chronic obstructive pulmonary disease	0.00216	0.0189	CbGeAlD
Arsenic trioxide—CCND1—lung—chronic obstructive pulmonary disease	0.00214	0.0187	CbGeAlD
Arsenic trioxide—AKT1—trachea—chronic obstructive pulmonary disease	0.00209	0.0183	CbGeAlD
Arsenic trioxide—JUN—bronchus—chronic obstructive pulmonary disease	0.00203	0.0177	CbGeAlD
Arsenic trioxide—IKBKB—bronchus—chronic obstructive pulmonary disease	0.00202	0.0176	CbGeAlD
Arsenic trioxide—JUN—smooth muscle tissue—chronic obstructive pulmonary disease	0.00198	0.0173	CbGeAlD
Arsenic trioxide—IKBKB—smooth muscle tissue—chronic obstructive pulmonary disease	0.00198	0.0173	CbGeAlD
Arsenic trioxide—JUN—trachea—chronic obstructive pulmonary disease	0.00182	0.0159	CbGeAlD
Arsenic trioxide—MAPK1—lung—chronic obstructive pulmonary disease	0.0018	0.0157	CbGeAlD
Arsenic trioxide—TXNRD1—lung—chronic obstructive pulmonary disease	0.00168	0.0147	CbGeAlD
Arsenic trioxide—MAPK3—lung—chronic obstructive pulmonary disease	0.00159	0.0139	CbGeAlD
Arsenic trioxide—AKT1—lung—chronic obstructive pulmonary disease	0.0015	0.0131	CbGeAlD
Arsenic trioxide—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.00131	0.0115	CbGeAlD
Arsenic trioxide—JUN—lung—chronic obstructive pulmonary disease	0.00131	0.0114	CbGeAlD
Arsenic trioxide—IKBKB—lung—chronic obstructive pulmonary disease	0.0013	0.0114	CbGeAlD
Arsenic trioxide—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.00116	0.0101	CbGeAlD
Arsenic trioxide—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00106	0.00925	CbGeAlD
Arsenic trioxide—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000929	0.00812	CbGeAlD
Arsenic trioxide—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000765	0.00668	CbGeAlD
Arsenic trioxide—CYP1B1—lung—chronic obstructive pulmonary disease	0.000698	0.0061	CbGeAlD
Arsenic trioxide—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000687	0.006	CbGeAlD
Arsenic trioxide—CYP1A1—lung—chronic obstructive pulmonary disease	0.000493	0.00431	CbGeAlD
Arsenic trioxide—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000483	0.00422	CbGeAlD
Arsenic trioxide—ABCB1—trachea—chronic obstructive pulmonary disease	0.000357	0.00312	CbGeAlD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.000295	0.0571	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000291	0.0564	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000291	0.0564	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.0558	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.055	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.055	CbGdCrCtD
Arsenic trioxide—TXNRD1—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.0526	CbGdCrCtD
Arsenic trioxide—ABCB1—lung—chronic obstructive pulmonary disease	0.000256	0.00224	CbGeAlD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000144	0.0279	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000144	0.0279	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.0273	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.0273	CbGdCrCtD
Arsenic trioxide—MAPK3—Immune System—ERBB3—chronic obstructive pulmonary disease	1.63e-05	6.51e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.62e-05	6.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.62e-05	6.48e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CRP—chronic obstructive pulmonary disease	1.6e-05	6.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD8A—chronic obstructive pulmonary disease	1.6e-05	6.37e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.59e-05	6.34e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.59e-05	6.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	1.59e-05	6.34e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.58e-05	6.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.56e-05	6.23e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.56e-05	6.23e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB3—chronic obstructive pulmonary disease	1.55e-05	6.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB3—chronic obstructive pulmonary disease	1.55e-05	6.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.55e-05	6.18e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	6.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.54e-05	6.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CRP—chronic obstructive pulmonary disease	1.54e-05	6.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—TLR4—chronic obstructive pulmonary disease	1.53e-05	6.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	6.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.53e-05	6.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	1.52e-05	6.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.52e-05	6.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.51e-05	6.04e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.51e-05	6.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB3—chronic obstructive pulmonary disease	1.51e-05	6.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.5e-05	6e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.49e-05	5.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—chronic obstructive pulmonary disease	1.49e-05	5.95e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB3—chronic obstructive pulmonary disease	1.48e-05	5.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—IL6—chronic obstructive pulmonary disease	1.48e-05	5.92e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—TLR4—chronic obstructive pulmonary disease	1.47e-05	5.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.46e-05	5.82e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.45e-05	5.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.45e-05	5.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.44e-05	5.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB3—chronic obstructive pulmonary disease	1.43e-05	5.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—TLR4—chronic obstructive pulmonary disease	1.43e-05	5.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.43e-05	5.71e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.42e-05	5.67e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.42e-05	5.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—chronic obstructive pulmonary disease	1.42e-05	5.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	5.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—IL6—chronic obstructive pulmonary disease	1.41e-05	5.64e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.41e-05	5.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.41e-05	5.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.4e-05	5.61e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.39e-05	5.56e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.38e-05	5.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.38e-05	5.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.38e-05	5.5e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.38e-05	5.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TLR4—chronic obstructive pulmonary disease	1.36e-05	5.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—chronic obstructive pulmonary disease	1.36e-05	5.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.35e-05	5.4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	5.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.34e-05	5.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.34e-05	5.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.34e-05	5.34e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.32e-05	5.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.31e-05	5.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.31e-05	5.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.31e-05	5.23e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.31e-05	5.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TLR4—chronic obstructive pulmonary disease	1.3e-05	5.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.3e-05	5.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS2—chronic obstructive pulmonary disease	1.29e-05	5.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.28e-05	5.11e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	5.11e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.27e-05	5.08e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.27e-05	5.06e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	5.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS2—chronic obstructive pulmonary disease	1.25e-05	5.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.25e-05	5.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.25e-05	4.99e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.24e-05	4.97e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.24e-05	4.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.23e-05	4.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.22e-05	4.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.2e-05	4.81e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.2e-05	4.81e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.2e-05	4.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS2—chronic obstructive pulmonary disease	1.19e-05	4.77e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.18e-05	4.72e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.18e-05	4.72e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	4.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.17e-05	4.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—chronic obstructive pulmonary disease	1.17e-05	4.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.16e-05	4.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.16e-05	4.62e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.14e-05	4.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	4.55e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	4.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—chronic obstructive pulmonary disease	1.13e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.13e-05	4.52e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.12e-05	4.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	4.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.11e-05	4.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.1e-05	4.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.09e-05	4.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.09e-05	4.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	4.35e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.09e-05	4.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.09e-05	4.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—chronic obstructive pulmonary disease	1.08e-05	4.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.07e-05	4.28e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.06e-05	4.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.06e-05	4.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.06e-05	4.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SERPINE1—chronic obstructive pulmonary disease	1.06e-05	4.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.06e-05	4.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.05e-05	4.21e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.05e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.05e-05	4.19e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.05e-05	4.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.05e-05	4.18e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.04e-05	4.16e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS3—chronic obstructive pulmonary disease	1.04e-05	4.15e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.03e-05	4.11e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	4.09e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.02e-05	4.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.02e-05	4.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.01e-05	4.05e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.01e-05	4.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.01e-05	4.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS3—chronic obstructive pulmonary disease	1.01e-05	4.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.01e-05	4.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	4.02e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—chronic obstructive pulmonary disease	1e-05	4.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1e-05	4.01e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—chronic obstructive pulmonary disease	9.98e-06	3.99e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.72e-06	3.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.65e-06	3.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.64e-06	3.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS3—chronic obstructive pulmonary disease	9.6e-06	3.83e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.6e-06	3.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—chronic obstructive pulmonary disease	9.59e-06	3.83e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.51e-06	3.8e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.44e-06	3.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.43e-06	3.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.35e-06	3.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—chronic obstructive pulmonary disease	9.3e-06	3.71e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.24e-06	3.69e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ALB—chronic obstructive pulmonary disease	9.11e-06	3.64e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.07e-06	3.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.97e-06	3.58e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.97e-06	3.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.9e-06	3.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—chronic obstructive pulmonary disease	8.85e-06	3.53e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.71e-06	3.48e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.64e-06	3.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.59e-06	3.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.51e-06	3.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—chronic obstructive pulmonary disease	8.47e-06	3.38e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.18e-06	3.27e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8e-06	3.19e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.95e-06	3.18e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.94e-06	3.17e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.91e-06	3.16e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.87e-06	3.14e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.76e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.75e-06	3.1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.63e-06	3.05e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—chronic obstructive pulmonary disease	7.6e-06	3.04e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.58e-06	3.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	7.57e-06	3.02e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.54e-06	3.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.4e-06	2.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.38e-06	2.95e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—chronic obstructive pulmonary disease	7.3e-06	2.92e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.28e-06	2.91e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.24e-06	2.89e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.24e-06	2.89e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—chronic obstructive pulmonary disease	7.09e-06	2.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.07e-06	2.82e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.04e-06	2.81e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—chronic obstructive pulmonary disease	6.88e-06	2.75e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—chronic obstructive pulmonary disease	6.74e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—chronic obstructive pulmonary disease	6.74e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.74e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.73e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.72e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—chronic obstructive pulmonary disease	6.67e-06	2.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—chronic obstructive pulmonary disease	6.54e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.46e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—chronic obstructive pulmonary disease	6.45e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.43e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—chronic obstructive pulmonary disease	6.35e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.29e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.27e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—chronic obstructive pulmonary disease	6.22e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.2e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.14e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.08e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.96e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.96e-06	2.38e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.84e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—chronic obstructive pulmonary disease	5.84e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.78e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.71e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.67e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.67e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—chronic obstructive pulmonary disease	5.61e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.59e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.53e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.48e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.46e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—chronic obstructive pulmonary disease	5.45e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.39e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.25e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—chronic obstructive pulmonary disease	5.18e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—chronic obstructive pulmonary disease	5.18e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.16e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.09e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.04e-06	2.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—chronic obstructive pulmonary disease	5.03e-06	2.01e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.01e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—chronic obstructive pulmonary disease	4.96e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.92e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.84e-06	1.93e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.82e-06	1.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—chronic obstructive pulmonary disease	4.78e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.72e-06	1.89e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.67e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.66e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.65e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.63e-06	1.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.58e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.46e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.45e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.36e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.25e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.17e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.13e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.97e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.87e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.85e-06	1.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.82e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.78e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.72e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.66e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.63e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.56e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.56e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.52e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.5e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.38e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.35e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.2e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.29e-06	9.16e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.19e-06	8.77e-06	CbGpPWpGaD
